Acanthosis nigricans and insulin sensitivity in patients with achondroplasia and hypochodroplasia due to FGFR3 mutations

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3959-3963

  Alatzoglou, Kyriaki S ^a   Hindmarsh, Peter C ^a   Brain, Caroline ^b   Torpiano, John ^c   Dattani, Mehul T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c MATER DEI HOSPITAL   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLUCOSE; INSULIN; RECOMBINANT GROWTH HORMONE;

ACANTHOSIS NIGRICANS; ACHONDROPLASIA; ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROUZON SYNDROME; DEVELOPMENTAL DISORDER; GENE MUTATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOCHONDROPLASIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SADDAN SYNDROME; SHORT STATURE; STATISTICAL ANALYSIS; SYNDROME; THANATOPHORIC DWARFISM;

EID: 70349902767     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0322     Document Type: Article

References (20)

1. Vajo Z, Francomano CA, Wilkin DJ 2000 The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 21: 23-39
2. Torley D, Bellus GA, Munro CS 2002 Genes, growth factors and acanthosis nigricans. Br J Dermatol 147:1096-1101 (Pubitemid 36963014)
3. Berk DR, Spector EB, Bayliss SJ 2007 Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol 143:1153-1156
4. Castro-Feijóo L, Loidi L, Vidal A, Parajes S, Rosón E, Alvarez A, Cabanas P, Barreiro J, Alonso A, Domínguez F, Pombo M 2008 Hypochondroplasia and acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene? Eur J Endocrinol 159:243-249
5. Van Esch H, Fryns JE 2004 Acanthosis nigricans in a boy with achondroplasia due to the classical Gly380Arg mutation in FGFR3. Genet Couns 15:375-377 (Pubitemid 39318380)
6. Downs AM, Kennedy CT 1999 Somatotrophin-induced acanthosis nigricans. Br J Dermatol 141:390-391
7. Leroy JG, Nuytinck L, Lambert J, Naeyaert JM, Mortier GR 2007 Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene. Am J Med Genet A 143A: 3144-3149 (Pubitemid 350274830)
8. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J 2000 Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301 (Pubitemid 30131733)
9. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
10. L'Hôte CG, Knowles MA 2005 Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 304:417-431
11. Heuertz S, Le Merrer M, Zabel B, Wright M, Legeai-Mallet L, Cormier-Daire V, Gibbs L, Bonaventure J 2006 Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Eur J Hum Genet 14:1240-1247 (Pubitemid 44804029)
12. 2000 Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care 23:381-389
13. Hyland VJ, Robertson SP, Flanagan S, Savarirayan R, Roscioli T, Masel J, Hayes M, Glass IA 2003 Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia.Am J Med Genet A 120A:157-168
14. LogiéA, Dunois-LardéC, Rosty C, Levrel O, Blanche M, Ribeiro A, Gasc JM, Jorcano J, Werner S, Sastre-Garau X, Thiery JP, Radvanyi F 2005 Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 14:1153-1160 (Pubitemid 40613904)
15. Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A 2006 Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 116:2201-2207 (Pubitemid 44162329)
16. Shepard TH, Bass GL 1971 Organ-culture studies of achondroplastic rabbit cartilage: evidence for a metabolic defect in glucose utilization. J Embryol Exp Morphol 25:347-363
17. Collipp PJ, Sharma RK, Thomas J, Maddaiah VT, Chen SY 1972 Abnormal glucose tolerance in children with achondroplasia. Am J Dis Child 124:682-685
18. Hertel NT, Eklöf O, Ivarsson S, Aronson S, Westphal O, SipiläI, Kaitila I, Bland J, Veimo D, Müller J, Mohnike K, Neumeyer L, Ritzen M, Hagenäs L 2005 Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial. Acta Paediatr 94:1402-1410 (Pubitemid 41510649)
19. Arnaud-Dabernat S, Kritzik M, Kayali AG, Zhang YQ, Liu G, Ungles C, Sarvetnick N 2007 FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells. Diabetes 56:96-106 (Pubitemid 46263116)
20. Oka M, Kageyama A, Fukunaga M, Bito T, Nagai H, Nishigori C 2004 Phosphatidylinositol 3-kinase/Akt-dependent and -independent protection against apoptosis in normal human melanocytes. J Invest Dermatol 123:930-936 (Pubitemid 39391940)